ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
-0,50%
Bitcoin
66.781,72
2,36%
Brent Oil
83,76
0,67%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Principia Biopharma Inc (PRNB)

  7. Principia Biopharma Inc (PRNB) Notícias

PRNB

Principia Biopharma (PRNB)

Principia Biopharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRNB
DataHoraFonteTítuloCódigoCompanhia
16/02/202117:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRNBPrincipia Biopharma Inc
24/11/202010:00GlobeNewswire Inc.Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for RilzabrutinibNASDAQ:PRNBPrincipia Biopharma Inc
08/10/202008:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PRNBPrincipia Biopharma Inc
01/10/202007:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202018:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202010:20Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202010:12Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202009:49Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202009:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202007:35Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202007:31Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRNBPrincipia Biopharma Inc
17/09/202009:01GlobeNewswire Inc.Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related DiseaseNASDAQ:PRNBPrincipia Biopharma Inc
10/09/202009:00GlobeNewswire Inc.Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of DirectorsNASDAQ:PRNBPrincipia Biopharma Inc
28/08/202002:44Dow Jones NewsSanofi to Launch Tender Offer for Principia AcquisitionNASDAQ:PRNBPrincipia Biopharma Inc
25/08/202013:33Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PRNBPrincipia Biopharma Inc
21/08/202007:01Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PRNBPrincipia Biopharma Inc
20/08/202017:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PRNBPrincipia Biopharma Inc
19/08/202014:50Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRNBPrincipia Biopharma Inc
18/08/202007:01Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PRNBPrincipia Biopharma Inc
18/08/202004:02Dow Jones NewsSanofi Buys MS-Drug Development Partner -- WSJNASDAQ:PRNBPrincipia Biopharma Inc
17/08/202014:51Dow Jones NewsSanofi to Buy U.S. Developer of Multiple Sclerosis Treatment -- 2nd UpdateNASDAQ:PRNBPrincipia Biopharma Inc
17/08/202007:10Dow Jones NewsSanofi to Buy U.S. Developer of Multiple Sclerosis Treatment--UpdateNASDAQ:PRNBPrincipia Biopharma Inc
17/08/202004:25Dow Jones NewsSanofi to Acquire US Company Principia Biopharma for $3.68 Billion -- UpdateNASDAQ:PRNBPrincipia Biopharma Inc
17/08/202003:22Dow Jones NewsCorrection to Sanofi ArticleNASDAQ:PRNBPrincipia Biopharma Inc
17/08/202003:06Dow Jones NewsSanofi to Acquire US Company Principia Biopharma for $3.68 BillionNASDAQ:PRNBPrincipia Biopharma Inc
17/08/202002:00PR Newswire (US)Sanofi to acquire Principia BiopharmaNASDAQ:PRNBPrincipia Biopharma Inc
06/08/202017:34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PRNBPrincipia Biopharma Inc
06/08/202017:05GlobeNewswire Inc.Principia Biopharma Reports Second Quarter 2020 Financial ResultsNASDAQ:PRNBPrincipia Biopharma Inc
17/07/202003:29Dow Jones NewsSanofi Is Looking at US Biotech Acquisitions -BloombergNASDAQ:PRNBPrincipia Biopharma Inc
23/06/202002:15GlobeNewswire Inc.Principia Announces First Patient Enrolled in Sanofi’s Phase 3 Trial of SAR442168 in Relapsing Multiple SclerosisNASDAQ:PRNBPrincipia Biopharma Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRNB

Seu Histórico Recente

ASE
ELBE
Elve S A
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados